Department of Defense (DOD) Fiscal Year 2006 (FY06) Prostate Cancer Research Program (PCRP) Idea Development Award

The summary for the Department of Defense (DOD) Fiscal Year 2006 (FY06) Prostate Cancer Research Program (PCRP) Idea Development Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.

Department of Defense (DOD) Fiscal Year 2006 (FY06) Prostate Cancer Research Program (PCRP) Idea Development Award: The intent of the PCRP Idea Development Award is to encourage innovative, high impact approaches to prostate cancer research from prostate cancer investigators and investigators in other fields who want to move into prostate cancer research. The Idea Development Award supports innovative, high-risk/high-reward prostate cancer research. The PCRP seeks proposals from all areas of laboratory, preclinical, behavioral, and epidemiological research, including clinical trials. Important aspects of the Idea Development Award are as follows: 1. Innovation: Innovation is a significant feature of the Idea Development Award. Research deemed innovative may represent a new paradigm, challenge existing paradigms, or look at existing problems from new perspectives. It is the responsibility of the applicant to clearly and explicitly articulate how the proposed research is innovative. Proposals may be innovative in a variety of ways, including the following: Study concept - investigation of a novel idea and/or unique research question that has the potential to advance the field of prostate cancer research in a significant way. Research method or technology - use of novel research methods or new technologies to address a research question that could not be addressed using conventional methods/techniques. Clinical interventions - use of a novel method or technology for preventing, diagnosing, or treating prostate cancer. Adaptations of existing methods or technologies - application or adaptation of existing methods or technologies for research or clinical purposes that are fundamentally different from those originally intended, and/or for use in novel research or clinical purposes. This list is intended to serve as a foundation on which to frame and present the innovative features of the proposal. Conversely, examples of research that is not innovative, and will not be considered for funding under this mechanism include: Exploring a hypothesis in a different cell line. Using a published series of in vitro assays to further characterize a model system. Incorporating known biomarkers into in vitro or clinical models of prostate cancer. 2. Impact: Research that has high impact may significantly advance current methods, concepts, prevention, diagnosis, or treatment of prostate cancer or quality of life for patients. It is the responsibility of the applicant to clearly and explicitly articulate the impact the proposed research may have on the field of prostate cancer research. 3. Preliminary Data: All Idea Development Award proposals must include preliminary data relevant to prostate cancer research and the proposed project. 4. Applicant Experience: The applicant should include a summary of his or her research and professional experience in prostate cancer or potential for contribution to the field of prostate cancer